『Scrubcast』のカバーアート

Scrubcast

Scrubcast

著者: Stanford Surgery
無料で聴く

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

Welcome to Scrubcast, the official podcast of the Stanford Department of Surgery! Join us as we delve into the fascinating world of surgery, where we spotlight the groundbreaking research, innovations, and stories shaping the future of medicine. Scrubcast features candid interviews with distinguished surgeons, insightful discussions on new surgical techniques, and conversations that highlight important issues in surgical practice and education. Whether you’re a medical professional, student, or simply curious about the surgical field, Scrubcast offers an engaging and accessible exploration ofStanford Surgery 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Innovative Approaches to Abdominal Cancer: A Deep Dive into HIPEC and PIPAC with Dr. Byrne Lee
    2026/04/01
    In this episode of Scrubcast, host Rachel Baker speaks with Dr. Byrne Lee, a clinical professor specializing in surgical oncology at Stanford University. Dr. Lee shares his personal connection to cancer, discussing how family experiences have shaped his dedication to the field. The episode delves into innovative treatments such as Heated Intraperitoneal Chemotherapy (HIPEC) and the emerging technique of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC), highlighting their roles in treating cancers that have spread to the abdominal cavity. Dr. Lee emphasizes the importance of a patient-centered approach in cancer care, offering insights into the evolving landscape of treatment options and the crucial role of multidisciplinary collaboration in improving patient outcomes. Listeners will gain a deeper understanding of not only the technical aspects of these advanced therapies but also the emotional and ethical considerations that accompany cancer treatment. Through personal anecdotes and professional insights, Dr. Lee inspires hope and resilience in the face of challenging diagnoses. Link to “Results of the First Phase I PIPAC Trial in the United States: Braving the Storm:” https://link.springer.com/article/10.1245/s10434-023-14353-y
    続きを読む 一部表示
    21 分
  • Where Cancer and Cardiovascular Health Meet with Dr. Nazish Sayed
    2026/03/02
    Scubcast welcomes back Dr. Nazish Sayed, an associate professor in the Division of Vascular Surgery, for a discussion on the latest research in cardio vascular health. In this episode, Dr. Sayed reflects on the enduring benefits of statins, delves into the intricacies of tyrosine kinase inhibitors and their effects on vascular endothelial cells, and introduces innovative approaches in studying vascular Ehlers Danlos syndrome. He also shares personal experiences as both a clinician and cancer survivor, shedding light on the emotional journey of patients navigating "scanxiety." Tune in to explore cutting-edge advancements in cardio-oncology and precision medicine that promise to improve patient care and outcomes in this fascinating field.
    続きを読む 一部表示
    20 分
  • Exploring the Intersection of Surgery and Cancer Research with Dr. Dan Delitto
    2026/02/02
    Dr. Dan Delitto is an assistant professor of surgery at Stanford University specializes in surgical oncology and holds a PhD in immunology. On this episode, Dr. Delitto reflects on his decision to pursue an MD-PhD pathway during residency and discusses the recent advancements in single-cell RNA sequencing technology that his lab has acquired. He explains the complex role of fibroblasts in cancer development, particularly in pancreatic ductal carcinoma, highlighting how these cells can both promote and hinder tumor growth. The conversation includes a lightning round, during which Dr. Delitto shares his admiration for his mentor, Steve Hughes, and offers succinct advice on the importance of surgical experience. He also mentions his preference for trance music while working and shares his excitement about ongoing and future research projects in his lab, which include investigations into various cancers, such as sarcomas. Link to Nature Cancer article “Cancer-derived mitochondria fuel fibroblasts to become pro-tumorigenic.”: https://www.nature.com/articles/s43018-025-01005-1 Link to Cell Reports article “Disruption of fibroblast MYD88 signaling promotes antitumor immunity in pancreatic ductal adenocarcinoma”: https://www.cell.com/cell-reports/fulltext/S2211-1247(25)01118-0?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124725011180%3Fshowall%3Dtrue
    続きを読む 一部表示
    14 分
まだレビューはありません